Skip to main content
. 2017 Dec 15;8:1840. doi: 10.3389/fimmu.2017.01840

Figure 2.

Figure 2

Tumor-derived interleukin-6 (IL-6) is significantly correlated with the number of infiltrated myeloid-derived suppressor cells (MDSCs) in situ both at the mRNA and protein levels. (A) The expression of the IL-6 protein and CD33+ MDSCs infiltration in 253 paraffin-embedded breast tissues from cohort 1 and cohort 2 was studied by immunohistochemistry (IHC). We found greater MDSCs infiltration in cancer tissues with a high level of IL-6. (B) The correlation between the expression of IL-6 and MDSCs was compared both in cohort 1 and cohort 2 in situ (n = 253). The average number of MDSCs in the IL-6low group was significantly lower than that in the IL-6high group in both cohorts 1 and 2. Pearson correlation analysis revealed a positive correlation between the expression of IL-6 and the number of MDSCs in situ in both cohorts. (C) The infiltration percentage of the CD45+CD33+CD13+CD14CD15 subpopulation in 20 fresh breast cancer tissue samples was detected using flow cytometry. (1) The subpopulation was gated using anti-CD45 mAb and isotype control was used; (2) The CD45+CD33+CD13+CD14CD15 subpopulation in adjacent normal tissues. (3) The proportion of the interested subpopulation significantly increased in cancer tissues. (D) Based on the median relative RNA level of IL-6, breast cancer samples were divided into IL-6high and IL-6low groups. The average IL-6 mRNA level in the IL-6high group was 37.25-fold higher than that in the IL-6low group (P = 0.0093) (n = 20). (E) A higher frequency of MDSCs was detected in the IL-6high group compared to in the IL-6low group. (F) A correlation analysis on MDSCs number and IL-6 level was carried out (R2 = 0.4399, P = 0.0014) (n = 20). *P < 0.05, **P < 0.01, ***P < 0.001.